
SynBioBeta 2026 Speaker
Samuel King
Stanford University
BioEng Doctoral Candidate
Samuel King is a Ph.D. candidate in Bioengineering at Stanford University and the Arc Institute, advised by Dr. Brian Hie in the Laboratory of Evolutionary Design. He researches AI for biology, with the goal of understanding and designing genome-scale systems to improve human and planet health. Samuel works at the interface of computational and experimental biology, recently contributing to efforts developing the genome language models Evo 1 and Evo 2 and leading the creation of the world's first functional AI-generated genomes. He previously earned his M.S. from Stanford and his B.Sc. Hons. from the University of British Columbia.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


